PT  - JOURNAL ARTICLE
AU  - Christina Jost
AU  - Josef Hermann
AU  - Laila El-Shabrawi Caelen
AU  - Winfried Graninger
TI  - New onset psoriasis in a patient receiving abatacept for rheumatoid arthritis
AID  - 10.1136/bcr.09.2008.0845
DP  - 2009 Jan 01
TA  - BMJ Case Reports
PG  - bcr0920080845
VI  - 2009
4099  - http://casereports.bmj.com/content/2009/bcr.09.2008.0845.short
4100  - http://casereports.bmj.com/content/2009/bcr.09.2008.0845.full
AB  - Administration of abatacept is a new treatment modality for rheumatoid arthritis (RA). We describe a patient in whom psoriasiform skin lesions developed 4 months after the initiation of abatacept therapy for longstanding, rheumatoid factor positive RA. Histological findings were consistent with psoriasis. The skin lesions subsided after discontinuation of abatacept and reappeared after re-exposure to the drug, suggesting a causal connection between abatacept and the development of psoriasis.